Positions

Selected Publications

Academic Article

Year Title Altmetric
2018 Immunotherapy of Guillain-Barré syndrome 2018
2018 Glial-derived neurotrophic factor is essential for blood-nerve barrier functional recovery in an experimental murine model of traumatic peripheral neuropathy 2018
2017 The Human Blood-Nerve Barrier Transcriptome 2017
2017 Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy 2017
2017 A novel method for measuring hydraulic conductivity at the human blood-nerve barrier in vitro 2017
2016 "Small Blood Vessels: Big Health Problems?": Scientific Recommendations of the National Institutes of Health Workshop 2016
2016 The pathogenic relevance of αM-integrin in Guillain–Barré syndrome 2016
2016 Modeling leukocyte trafficking at the human blood-nerve barrier in vitro and in vivo geared towards targeted molecular therapies for peripheral neuroinflammation 2016
2015 Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention 2015
2015 Osteoblasts Have a Neural Origin in Heterotopic Ossification 2015
2014 VIP-expressing dendritic cells protect against spontaneous autoimmune peripheral polyneuropathy. 2014
2014 CCR2 Gene deletion and pharmacologic blockade ameliorate a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome 2014
2014 VIP-expressing dendritic cells protect against spontaneous autoimmune peripheral polyneuropathy 2014
2013 A man with small vessel vasculitis presenting with brachial diplegia, multiple cranial mononeuropathies and severe orthostatic hypotension in diabetes mellitus: A case report 2013
2013 A case of severe chronic progressive axonal polyradiculoneuropathy temporally associated with anti-CV2/CRMP5 antibodies 2013
2013 The role of chemokines in guillain-barré syndrome 2013
2013 VEGF-A165 Potently induces human blood-nerve barrier endothelial cell proliferation, angiogenesis, and wound healing in vitro 2013
2013 An immortalized human blood-nerve barrier endothelial cell line for in vitro permeability studies 2013
2013 Chemokine-dependent signaling pathways in the peripheral nervous system 2013
2013 The molecular and biophysical characterization of the human blood-nerve barrier: Current concepts 2013
2012 Translational strategies in peripheral neuroinflammation and neurovascular repair 2012
2012 α Mβ 2-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain-Barré syndrome patient derived mononuclear leukocytes at the blood-nerve barrier in vitro 2012
2012 Subacute brachial diplegia associated with west nile virus myelitis 2012
2012 GDNF restores human blood-nerve barrier function via RET tyrosine kinase-mediated cytoskeletal reorganization 2012
2012 Behavioral, electrophysiological, and histopathological characterization of a severe murine chronic demyelinating polyneuritis model 2012
2012 Transient brown adipocyte-like cells derive from peripheral nerve progenitors in response to bone morphogenetic protein 2 2012
2011 Chemokine receptors as specific anti-inflammatory targets in peripheral nerves 2011
2010 Dorsal caudal tail and sciatic motor nerve conduction studies in adult mice: Technical aspects and normative data 2010
2010 Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome 2010
2010 Development and characterization of a novel human in vitro blood-nerve barrier model using primary endoneurial endothelial cells 2010
2010 Selective expression and cellular localization of pro-inflammatory chemokine ligand/receptor pairs in the sciatic nerves of a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome 2010
2009 Dynamic properties of eye movements in mitochondrial chronic progressive external ophthalmoplegia 2009
2008 Interferon-α-2b/ribavirin-induced vestibulocochlear toxicity with dysautonomia in a chronic hepatitis C patient 2008
2008 Predictors of Clinical Outcome and Mortality in Vertebrobasilar Dolichoectasia Diagnosed by Magnetic Resonance Angiography 2008
2008 Human brain microvascular endothelial cells and umbilical vein endothelial cells differentially facilitate leukocyte recruitment and utilize chemokines for T cell migration 2008
2007 Chronic inflammatory demyelinating polyradiculoneuropathy presenting as cauda equina syndrome in a diabetic 2007
2007 Inflammatory cell migration into the central nervous system: A few new twists on an old tale 2007
2007 "Doing the locomotion" with the multistep paradigm 2007
2006 CCR5 expression on monocytes and T cells: Modulation by transmigration across the blood-brain barrier in vitro 2006
2006 Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation 2006
2006 Electrodiagnostic criteria for carpal tunnel syndrome in axonal polyneuropathy 2006
2006 Modulating CCR2 and CCL2 at the blood-brain barrier: Relevance for multiple sclerosis pathogenesis 2006
2006 The expression and function of chemokines involved in CNS inflammation 2006
2005 Adult polyglucosan body disease: A case report of a manifesting heterozygote 2005
2005 Complete innervation of extensor digitorum brevis by accessory peroneal nerve 2005
2005 Intracranial arterial dolichoectasia is associated with enlarged descending thoracic aorta [1] (multiple letters) 2005
2004 Clinical and radiological features of symptomatic cerebral perfusion failure due to carotid artery occlusion surgically corrected by extracranial-intracranial bypass surgery [2] 2004
2004 Asymptomatic middle cerebral artery stenosis diagnosed by magnetic resonance angiography. 2004
2004 Transverse myelitis associated with Acinetobacter baumanii intrathecal pump catheter-related infection. Where was the source of the infection? [1] (multiple letters) 2004
2004 Vertebrobasilar dolichoectasia diagnosed by magnetic resonance angiography and risk of stroke and death: A cohort study 2004
2003 Adverse Reactions to Mirtazapine are Unlikely to be Serotonin Toxicity [1] 2003
2003 Mirtazapine-induced serotonin syndrome 2003
2003 Ketamine for refractory status epilepticus : A case of possible ketamine-induced neurotoxicity 2003
2003 Transverse myelitis associated with Acinetobacter baumanii intrathecal pump catheter-related infection 2003
2002 Rectus sheath hematoma complicating percutaneous endoscopic gastrostomy 2002
2002 Cervicomedullary junction compression caused by vertebral artery dolichoectasia and requiring surgical treatment 2002
2002 Otalgia as the sole presenting manifestation of subdural hematoma 2002
2002 Recurrent transient ischemic attacks as the initial presenting manifestation of type A aortic dissection 2002
2001 The preferential involvement of extraocular muscles by myasthenia gravis 2001
2001 Amaurosis fugax associated with phencyclidine inhalation 2001
2001 Acute motor-sensory axonal neuropathy associated with active systemic lupus erythematosus and anticardiolipin antibodies 2001

Book

Year Title Altmetric
2013 Preface.  Ed. 1013.  2013
2005 Neurology oral boards review: A concise and systematic approach to clinical practice 2005

Chapter

Year Title Altmetric
2014 Atypical motor neuron disorders.  441-466. 2014
2007 G.  81-89. 2007

Principal Investigator On

  • Topiramate as a Disease Altering Therapy for Cryptogenic Sensory Peripheral Neuropalhy (CSPN)  awarded by MASSACHUSETTS GENERAL HOSPITAL 2017 - 2023
  • A Phase ll of Rituximab in Myasthenia Gravis (NN 103)  awarded by MASSACHUSETTS GENERAL HOSPITAL 2015 - 2023
  • CD11d Antagonism For Chronic Inflammatory Neuropathies  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2019 - 2021
  • Schwann Cell Control of Blood-Nerve Barrier Structure and Function  awarded by University of Wisconsin-Madison 2019 - 2020
  • UAB MDA CARE CENTER  awarded by Muscular Dystrophy Association 2017 - 2019
  • Private Grant  awarded by Genzyme Corporation 2017 - 2019
  • Private Grant  awarded by CSL BEHRING, LLC 2014 - 2019
  • Characterization of Agrin/LRP4 Antibody-Positive Myastenia Gravis  awarded by GEORGIA REGENTS UNIVERSITY (AUGUSTA) 2018 - 2019
  • Private Grant  awarded by CATALYST PHARMACEUTICAL PARTNERS, INC. 2016 - 2019
  • Vascular Biology of the Human Blood-Nerve Barrier  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2013 - 2018
  • Characterization of Agrin/LRP4 Antibody-Positive Myasthenia Gravis  awarded by GEORGIA REGENTS UNIVERSITY (AUGUSTA) 2015 - 2017
  • Private Grant  awarded by CATALYST PHARMACEUTICAL PARTNERS, INC. 2015 - 2017
  • Private Grant  awarded by CSL BEHRING, LLC 2013 - 2017
  • MDA Sponsored Clinic Grant  awarded by Muscular Dystrophy Association 2014 - 2016
  • Alpha M Beta 2 Integrin Blockade for Acute Inflammatory Neuropathies  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2013 - 2015
  • Fibronectin Peptide Antagonism for Chronic Inflammatory Neuropathies  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2013 - 2014
  • Education And Training

  • Cleveland Clinic Foundation, Internship 2000
  • University Hospitals of Cleveland, Residency 2003
  • Emory University School of Medicine, Postdoctoral Fellowship 2004
  • Full Name

  • Eroboghene Ubogu